Section Arrow
BNTC.NASDAQ
- Benitec Biopharma
Quotes are at least 15-min delayed:2026/02/19 19:18 EST
After Hours
Last
 10.84
0 (0.00%)
Bid
9.85
Ask
13
High 11.05 
Low 10.84 
Volume 6.89K 
Regular Hours (Closed)
Last
 10.84
+0.27 (+2.55%)
Day High 
11.13 
Prev. Close
10.57 
1-M High
13.11 
Volume 
188.03K 
Bid
9.85
Ask
13
Day Low
10.3 
Open
10.58 
1-M Low
9.85 
Market Cap 
362.07M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 11.4 
20-SMA 11.9 
50-SMA 12.22 
52-W High 17.15 
52-W Low 9.8 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.08/-1.92
Enterprise Value
362.57M
Balance Sheet
Book Value Per Share
5.45
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
829.13K
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TOVXTheriva Biologics Inc0.1967+0.0047+2.45%0.09PE
After Hours 0.1891 -0.0076 -3.86%
IBRXImmunityBio8.61+0.07+0.82%-- 
After Hours 8.5 -0.11 -1.28%
DRMADermata Therapeutics Inc1.93+0.65+50.78%0.08PE
After Hours 1.8099 -0.1201 -6.22%
QNCXQuince Therapeutics0.1622-0.0158-8.88%-- 
After Hours 0.163 +0.0008 +0.49%
LIMNLiminatus Pharma Inc0.2383-0.0066-2.69%-- 
After Hours 0.237 -0.0013 -0.55%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.